Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications originally developed for managing type 2 diabetes but increasingly recognised for their weight management properties
It exerts its effects through two primary pathways: direct binding to the GH receptor (GHR) on target tissues producing immediate metabolic effects including lipolysis, insulin antagonism, and protein synthesis and indirect stimulation of IGF-1 production in the liver and peripheral tissues, which mediates the majority of GHs anabolic and growth-promoting effects
While the powder gets good reviews on taste, some reviewers note the lack of flavor options as a downside
At higher levels, such as 0.25% to 0.40%, individuals experience stupor, unconsciousness, and respiratory depression, which is life-threatening
Shorter Wait Times We are proudly accessible and responsive to our patients